Potential Anticancer Activities and Catalytic Oxidation Efficiency of Platinum(IV) Complex.

The treatment of an aqueous acetonitrile solution of chloroplatinic acid hydrate H2PtCl6.xH2O and pyridine-2-carbaldehyde-oxime (paOH) in the presence of potassium thiocyanate at room temperature (25°) led to the formation of a new Pt(IV) complex with the formula [Pt(SCN)2(paO)2], (1). Complex 1 was fully characterized by FT-IR, UV-vis and NMR spectroscopic techniques as well as elemental analysis. The crystallographic structure of complex 1 was obtained by single-crystal X-ray diffraction. The structure of complex 1 consists of a distorted octahedral geometrical environment around the platinum center in which the coordination sites are occupied by two terminal thiocyanate ligands in trans arrangement and two bidentate paO ligands through four nitrogen atoms. In addition, the in vitro evaluation of the cytotoxicity of platinum complex 1 against four different cancer cell lines was performed. The IC50 values for colon (HCT116), liver (HepG2), breast (MCF-7) and erythroid (JK-1) treated with complex 1 are 19 ± 6, 21 ± 5, 22 ± 6, and 13 ± 3 µM, respectively. In HCT116 cells treated with the IC50 dose of our title compound, apoptosis and necrosis were increased by 34% and 27.8%, respectively. Cells halted in the proliferative phase (S phase) to 21.7 % and 29.8% in HCT116 and HepG2 cells treated with complex 1 have anti-proliferative actions. Furthermore, the catalytic activity of synthesized complex 1 was examined in the oxidation reaction of benzyl alcohols in the presence of an oxidant. Finally, the luminescence behavior of complex 1 was investigated.

DNA-Binding and Anticancer Activity of Binuclear Gold(I) Alkynyl Complexes with a Phenanthrenyl Bridging Ligand.

3,6-Diethynyl-9,10-diethoxyphenanthrene (4) was synthesized from phenanthrene and employed in the synthesis of the binuclear gold(I) alkynyl complexes (R3P)Au(C≡C-3-[C14H6-9,10-diethoxy]-6-C≡C)Au(PR3) (R = Ph (5a), Cy (5b)). The diyne 4 and complexes 5a and 5b were characterized by NMR spectroscopy, mass spectrometry, and elemental analysis. UV-Vis spectroscopy studies of the metal complexes and precursor diyne show strong p à p* transitions in the near UV region that red shift by ca. 50 nm upon coordination at the gold centers. The emission spectrum of 4 shows an intense fluorescence band centered at 420 nm which red shifts, slightly upon coordination of 4 to gold. Binding studies of 4, 5a, and 5b against calf thymus DNA were carried out, revealing that 4, 5a, and 5b have >40% stronger binding affinities than the commonly used intercalating agent ethidium bromide. The molecular docking scores of 4, 5a, and 5b with B-DNA suggest a similar trend in behavior to that observed in the DNA-binding study. Unlike the ligand 4, promising anticancer properties for 5a and 5b were observed against several cell lines; the DNA binding capability of the precursor alkyne was maintained, and its anticancer efficacy enhanced by the gold centers. Such phenanthrenyl complexes could be promising candidates in certain biological applications because the two components (phenanthrenyl bridge and metal centers) can be altered independently to improve the targeting of the complex, as well as the biological and physicochemical properties.

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (Poly)cyclic Aromatic Diamine Ligands.

Ruthenium(II) arene complexes of the general formula [RuCl(η6-p-cymene)(diamine)]PF6 (diamine = 1,2-diaminobenzene (1), 2,3-diaminonaphthalene (2), 9,10-diaminophenanthrene (3), 2,3-diaminophenazine (4), and 1,2-diaminoanthraquinone (5) were synthesized. Chloro/aqua exchange was evaluated experimentally for complexes 1 and 2. The exchange process was investigated theoretically for all complexes, revealing relatively fast exchange with no significant influence from the polycyclic aromatic diamines. The calf thymus DNA (CT-DNA) binding of the complexes increased dramatically upon extending the aromatic component of the diamines, as evaluated by changes in absorption spectra upon titration with different concentrations of CT-DNA. An intercalation binding mode was established for the complexes using the increase in the relative viscosity of the CT-DNA following addition of complexes 1 and 2. Theoretical studies showed strong preference for replacement of water by guanine for all the complexes, and relatively strong Ru-Nguanine bonds. The plane of the aromatic systems can assume angles that support non-classical interactions with the DNA and covalent binding, leading to higher binding affinities. The ruthenium arenes illustrated in this study have promising anticancer activities, with the half maximal inhibitory concentration (IC50) values comparable to or better than cisplatin against three cell lines.

Synthesis of Ni(II), Cu(II) and Co(II) complexes with new macrocyclic Schiff-base ligand containing dihydrazide moiety: Spectroscopic, structural, antimicrobial and antioxidant properties.

In this study, the macrocyclic Schiff base ligand (L) derived from 1, 4-dicarbonyl-phenyl-dihydrazide and glyoxal (2:2) and its Ni (II), Cu (II) and Co(II) complexes were synthesised and were characterised by elemental analyses, FTIR, UV-Vis., mass and 1H NMR. The ligand (L) behaves as a tetradentate ligand and coordinates to the metal ions via the nitrogen atoms and the complexes have the mononuclear structures. The synthesised compounds were evaluated for their inhibition potential against bacterial and fungal strains and the assay indicated that the metal complexes exhibited a remarkable antibacterial and antifungal activity against these tested strains. In addition, the antioxidant activity of the compounds was also studied through scavenging effect on DPPH radicals with the copper complex showing enhanced antioxidant activity than other metal complexes.

Optical Sensing Properties of Pyrene-Schiff Bases toward Different Acids.

A set of (4-substituted-phenyl)-pyren-1-ylmethylene-amine (PMA) was prepared by the reaction of pyrene-1-carboxaldehyde and the corresponding 4-substituted aniline. The structure of the PMA compounds were confirmed by spectroscopic data (IR, (1)HNMR, (13)CNMR, ISI-MS and elemental analysis. The structure of (4-bromo-phenyl)-pyren-1-ylmethylene-amine (BrPMA) was further confirmed by the single X-ray crystallography. The absorption and emission spectroscopic behaviors were investigated in variant acids. The compounds showed dramatic spectroscopic changes upon acidifying with strong acids and negligible effects when weak acids are used in the acidifications. Hence, the PMA compounds can be used as sensors to distinguish between weak and strong acids.

Tuning anticancer properties and DNA-binding of Pt(ii) complexes via alteration of nitrogen softness/basicity of tridentate ligands.

Nine tridentate Schiff base ligands of the type (N^N^O) were synthesized from reactions of primary amines {2-picolylamine (Py), N-phenyl-1,2-diaminobenzene (PhN), and N-phenyl-1,2-diaminoethane(EtN)} and salicylaldehyde derivatives {3-ethoxy (OEt), 4-diethylamine (NEt2) and 4-hydroxy (OH)}. Complexes with the general formula Pt(N^N^O)Cl were synthesized by reacting K2PtCl4 with the ligands in DMSO/ethanol mixtures. The ligands and their complexes were characterized by NMR spectroscopy, mass spectrometry and elemental analysis. The DNA-binding behaviours of the platinum(ii) complexes were investigated by two techniques, indicating good binding affinities and a two-stage binding process for seven complexes: intercalation followed by switching to a covalent binding mode over time. The other two complexes covalently bond to ct-DNA without intercalation. Theoretical calculations were used to shed light on the electronic and steric factors that lead to the difference in DNA-binding behavior. The reactions of some platinum complexes with guanine were investigated experimentally and theoretically. The binding of the complexes with bovine serum albumin (BSA) indicated a static interaction with higher binding affinities for the ethoxy-containing complexes. The half maximal inhibitory concentration (IC50) values against MCF-7 and HepG2 cell lines suggest that platinum complexes with tridentate ligands of N-phenyl-o-phenylenediamine or pyridyl with 3-ethoxysalicylimine are good chemotherapeutic candidates. Pt-Py-OEt and Pt-PhN-OEt have IC50 values against MCF-7 of 13.27 and 10.97 µM, respectively, compared to 18.36 µM for cisplatin, while they have IC50 values against HepG2 of 6.99 and 10.15 µM, respectively, compared to 19.73 µM for cisplatin. The cell cycle interference behaviour with HepG2 of selected complexes is similar to that of cisplatin, suggesting apoptotic cell death. The current work highlights the impact of the tridentate ligand on the biological properties of platinum complexes.

Tuning the anticancer properties of Pt(ii) complexes via structurally flexible N-(2-picolyl)salicylimine ligands.

Three tridentate Schiff base ligands were synthesized from the reactions between 2-picolylamine and salicylaldehyde derivatives (3-ethoxy (OEt), 4-diethylamino (NEt2) and 4-hydroxy (OH)). Complexes with the general formula Pt(N^N^O)Cl were obtained from reactions between the ligands and K2PtCl4. The ligands and their complexes were characterized by NMR spectroscopy, mass spectrometry and elemental analysis. Further confirmation of the structure of Pt-OEt was achieved by single-crystal X-ray diffraction. The DMSO/chlorido exchange process at Pt-OEt was investigated by monitoring the change in conductivity, revealing very slow dissociation in DMSO. Moreover, solvent/chlorido exchange for Pt-OEt and Pt-NEt2 were investigated by NMR spectroscopy in DMSO and DMSO/D2O; Pt-NEt2 forms an adduct with DMSO while Pt-OEt forms adducts with DMSO and water. The DNA-binding behaviour of the platinum(ii) complexes was investigated by two techniques. Pt-NEt2 has the best apparent binding constant. The intercalation mode of interaction with ct-DNA was suggested by molecular docking studies and the increase in the relative viscosity of ct-DNA with increasing concentrations of the platinum(ii) complexes. However, the gradual decrease in the relative viscosity over time at constant concentration of platinum(ii) complexes indicated a shift from intercalation to a covalent binding mode. Anticancer activities of the ligands and their platinum(ii) complexes were examined against two cell lines. The platinum(ii) complexes exhibit superior cytotoxicity to that of their ligands. Among the platinum(ii) complexes, Pt-OEt possesses the best IC50 against both cell lines, its cytotoxicity being comparable to that observed for cisplatin. Cell cycle arrest in the HepG2 cell line upon treatment with Pt-OEt and Pt-NEt2 was investigated and compared to that of cisplatin; the change in the cell accumulation patterns supports the presumption of an apoptotic cell death pathway. The optimized structures of the B-DNA trimer adducts with the platinum complexes showed hydrogen-bonding interactions between the ligands and nucleobases, affecting the inter-strand hydrogen bonding within the DNA, and highlighting the strong ability of the complexes to induce conformational changes in the DNA, leading to the activation of apoptotic cell death. In summary, the current study demonstrates promising new anticancer platinum(ii) complexes with highly flexible tridentate ligands; the functional groups on the ligands are important in tuning their DNA binding/anticancer properties.

Alteration of Anticancer and Protein-Binding Properties of Gold(I) Alkynyl by Phenolic Schiff Bases Moieties.

A set of five gold complexes with the general formula Au(PR3)(C≡C-C6H4-4-R') (R = PPh3, R' = -CHO (1), R = PCy3, R' = -CHO (2), R = PPh3, R' = -N=CH-C6H4-2-OH (3), R = PPh3, R' = -N=CH-C6H4-4-OH (4), R = PCy3, R' = -N=CH-C6H4-2-OH (5)) were synthesized and characterized by elemental analysis, 1H-NMR spectroscopy, 31P-NMR spectroscopy, and mass spectrometry. The structures of complexes 2 and 5 were determined by X-ray crystallography. The effects of the structural modifications on the protein binding affinities and anticancer activities of the five gold complexes were assessed. Fluorescence quenching experiments to assess binding to human serum albumin (HSA) revealed that the Schiff base complexes (3, 4, and 5) had binding constants that were superior to their parent aldehyde complexes and highlighted the position of the hydroxy group because complex 4 (4-hydroxy) had a binding constant 6400 times higher than complex 3 (2-hydroxy). The anticancer activities of the complexes against the OVCAR-3 (ovarian carcinoma) and HOP-62 (non-small-cell lung) cancer cell lines showed that the Schiff bases (3-5) were more cytotoxic than the aldehyde-containing complexes (1 and 2). Notably, compound 4 had cytotoxic activity comparable to that of cisplatin against OVCAR-3, demonstrating the significance of the para position for the hydroxy group. Molecular docking studies against the enzyme thioredoxin reductase (TrxR) and human serum albumin were conducted, with docking scores in good agreement with the experimental data. The current study highlights how small structural modifications can alter physiochemical and anticancer properties. Moreover, this simple design strategy using the aldehyde group can generate extensive opportunities to explore new gold(I)-based anticancer drugs via condensation, cyclization, or nucleophilic addition reactions of the aldehyde.

DNA-Binding and Cytotoxicity of Copper(I) Complexes Containing Functionalized Dipyridylphenazine Ligands.

A set of copper(I) coordination compounds with general formula [CuBr(PPh3)(dppz-R)] (dppz-R = dipyrido[3,2-a:2',3'-c]phenazine (Cu-1), 11-nitrodipyrido[3,2-a:2',3'-c]phenazine (Cu-2), 11-cyanodipyrido[3,2-a:2',3'-c]phenazine (Cu-3), dipyrido[3,2-a:2',3'-c]phenazine-11-phenone (Cu-4), 11,12-dimethyldipyrido[3,2-a:2',3'-c]phenazine (Cu-5)) have been prepared and characterized by elemental analysis, 1H-NMR and 31P-NMR spectroscopies as well as mass spectrometry. The structure of Cu-1 was confirmed by X-ray crystallography. The effect of incorporating different functional groups on the dppz ligand on the binding into CT-DNA was evaluated by absorption spectroscopy, fluorescence quenching of EtBr-DNA adducts, and viscosity measurements. The functional groups affected the binding modes and hence the strength of binding affinities, as suggested by the changes in the relative viscosity. The differences in the quenching constants (Ksv) obtained from the fluorescence quenching assay highlight the importance of the functional groups in altering the binding sites on the DNA. The molecular docking data support the DNA-binding studies, with the sites and mode of interactions against B-DNA changing with the different functional groups. Evaluation of the anticancer activities of the five copper compounds against two different cancer cell lines (M-14 and MCF-7) indicated the importance of the functional groups on the dppz ligand on the anticancer activities. Among the five copper complexes, the cyano-containing complex (Cu-3) has the best anticancer activities.

Linear Optical, Quadratic and Cubic Nonlinear Optical, Electrochemical, and Theoretical Studies of "Rigid-Rod" Bis-Alkynyl Ruthenium Complexes.

The syntheses of oligo(p-phenylene ethynylene)s (OPEs) end-functionalized by a nitro acceptor group and with a ligated ruthenium unit at varying locations in the OPE chain, namely, trans-[Ru{(C≡C-1,4-C6 H4 )n NO2 }(C≡CR)(dppe)2 ] (dppe=1,2-bis(diphenylphosphino)ethane; n=1, R=1,4-C6 H4 C≡C-1,4-C6 H4 C≡CPh, 1,4-C6 H4 NEt2 ; n=2, R=Ph, 1,4-C6 H4 C≡CPh, 1,4-C6 H4 C≡C-1,4-C6 H4 C≡CPh, 1,4-C6 H4 NO2 , 1,4-C6 H4 NEt2 ; n=3, R=Ph, 1,4-C6 H4 C≡CPh), are reported. Their electrochemical properties were assessed by cyclic voltammetry, their linear optical properties and quadratic and cubic nonlinear optical properties were assayed by UV/Vis/NIR spectroscopy, hyper-Rayleigh scattering studies employing nanosecond pulses at 1064 nm, and broad spectral range Z-scan studies employing femtosecond pulses, respectively, and their linear optical properties and vibrational spectroscopic behavior in the formally RuIII state was examined by UV/Vis/NIR and IR spectroelectrochemistry, respectively. The potentials of the metal-localized oxidation processes are sensitive to alkynyl-ligand modification, but this effect is attenuated on π-bridge lengthening. Computational studies employing time-dependent density functional theory were undertaken on model complexes, with a 2D scan revealing a soft potential-energy surface for intra-alkynyl-ligand aryl-ring rotation; this is consistent with the experimentally observed blueshift in optical absorption maxima. Quadratic optical nonlinearities are significant and cubic NLO coefficients for these small complexes are small. The optimum length of the alkynyl ligands and the ideal metal location in the OPE to maximize the key coefficients have been defined.

Crystal structure of trans-di-chloridobis-[N-(5,5-di-methyl-4,5-di-hydro-3H-pyrrol-2-yl-κN)acetamide]palladium(II) dihydrate.

The title complex, [PdCl2(C8H14N2O)2]·2H2O, was obtained by N-O bond cleavage of the oxa-diazo-line rings of the trans-[di-chlorido-bis-(2,5,5-trimethyl-5,6,7,7a-tetra-hydro-pyrrolo-[1,2-b][1,2,4]oxa-diazole-N1)]palladium(II) complex. The palladium(II) atom exhibits an almost square-planar coordination provided by two trans-arranged chloride anions and a nitro-gen atom from each of the two neutral organic ligands. In the crystal, N-H⋯O, O-H⋯O and O-H⋯Cl hydrogen bonds link complex mol-ecules into double layers parallel to the bc plane.

Syntheses, Electrochemical, Linear Optical, and Cubic Nonlinear Optical Properties of Ruthenium-Alkynyl-Functionalized Oligo(phenylenevinylene) Stars.

The syntheses of trans-[Ru(C≡CC6 H4 -4-CHO)(C≡CC6 H4 -4-R)(dppe)2 ] (R=H (9 a), NO2 (9 b), CHO (9 c), C≡CC6 H3 -3,5-Et2 (9 d), (E)-CHCHC6 H4 -4-tBu (9 e); dppe=1,2-bis(diphenylphosphino)ethane), trans-[Ru(C≡CC6 H4 -4-R)Cl(dppe)2 ] (R=C≡CC6 H3 -3,5-Et2 (11 a), (E)-CHCHC6 H4 -4-tBu (11 b), (E)-CHCHC6 H4 -4-NO2 (11 c)), 1,2,4,5-{trans-[(dppe)2 (RC6 H4 C≡C)Ru{C≡CC6 H4 -4-(E)-CHCH}]}4 C6 H2 (R=H (14 a), C≡CC6 H3 -3,5-Et2 (14 b), (E)-CHCHC6 H4 -4-tBu (14 c)), 1-I-3,5-{trans-[(L2 )2 (R)Ru{C≡CC6 H4 -4-(E)-CHCH}]}2 C6 H3 (L2 =1,1-bis(diphenylphosphino)methane (dppm)), R=Cl (15 a); L2 =dppe, R=C≡CPh (15 b), R=C≡CC6 H4 -4-NO2 (15 c)), 1-Me3 SiC≡C-3,5-{trans-[(L2 )2 (R)Ru{C≡CC6 H4 -4-(E)-CHCH}]}2 C6 H3 (L2 =dppm, R=Cl (16 a); L2 =dppe, R=C≡CPh (16 b)), 1-HC≡C-3,5-{trans-[(dppe)2 (R)Ru{C≡CC6 H4 -4-(E)-CHCH}]}2 C6 H3 (R=Cl (17 a), R=C≡CPh (17 b)), and 1,3,5-{trans-[(dppe)2 (3,5-R2 -C6 H3 C≡C)Ru{C≡CC6 H4 -4-(E)-CHCH}]}3 C6 H3 (R=(E)-CHCHC6 H4 -4-C≡C-trans-[Ru(C≡CPh)(dppe)2 ] (18)) are reported together with those of the precursor alkynes 1-RC≡C-3,5-Et2 C6 H3 (R=SiMe3 (2), H (3), C6 H4 -4-C≡CSiMe3 (5), C6 H4 -4-C≡CH (6)). The identities of 9 c, 9 d, 9 e, 11 a, and trans-[Ru{C≡CC6 H4 -4-(E)-CHCHC6 H4 -4-tBu}2 (dppe)2 ] (12 and 12') were confirmed by single-crystal X-ray diffraction studies. The electrochemical properties of 9 a-e, 11 a-b, 14 a-c, 15 a-c, 16 b, 17 a, 17 b, and 18 were assessed by cyclic voltammetry; the studies reveal that potentials for the fully/quasi-reversible metal-centered oxidation processes decrease upon introduction of solubilizing alkyl substituents and increase upon increasing acceptor substituent strength; other structural variations have little impact. UV/Vis-NIR spectroscopic studies on these complexes reveal lowest-energy metal-ligand charge transfer (MLCT) bands that redshift upon increasing the acceptor substituent strength, blueshift on alkyl incorporation, and gain in intensity on progression from linear to star complexes. Low-temperature UV/Vis-NIR spectroelectrochemical studies of 14 a-c show the appearance of an intense low-energy band at 7400-7900 cm-1 that is redshifted upon π-system lengthening and alkyl substituent incorporation. The cubic nonlinear optical properties of 9 d, 9 e, 14 a-c, 15 a-c, 16 b, 17 a, b, and 18 were assayed by femtosecond Z-scan studies at benchmark wavelengths (750 and 800 nm) in the near-IR region, with nonlinearity increasing upon nitro incorporation; the values for the E-ene-linked dendrimers in these studies are much larger than yne-linked analogues. Compounds 9 d, 9 e, 14 a-c, and 18 were further examined by broad-spectral-range femtosecond Z-scan studies; the cruciform complexes have appreciable multiphoton absorption cross-sections, with maximal values close to two and three times the wavelength of the linear optical absorption maxima.